Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2025-12-24 @ 1:20 PM
NCT ID:
NCT01768195
Eligibility Criteria:
Inclusion Criteria:
* treatment-naive patients with B-cell lymphoma
* HBsAg positive at baseline
* treated with rituximab-based immunochemotherapy
* life expectancy of more than 3 months
Exclusion Criteria:
* younger than 18 years old
* HBsAg negative at baseline
* pregnant or lactating women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01768195
Study Brief:
Protocol Section:
NCT01768195